查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1879003

RNA編輯技術市場－全球產業規模、佔有率、趨勢、機會和預測，按RNA類型、應用、技術、地區和競爭格局分類，2020-2030年預測

RNA Editing Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of RNA, By Application, By Technique, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球RNA編輯技術市場規模為2.6228億美元，預計2030年將以7.16%的複合年成長率成長至3.9716億美元。 RNA編輯技術是指在RNA分子轉錄後，透過分子過程精確修飾RNA分子內的特定核苷酸序列，這與對基因組DNA的永久性改變截然不同。該技術能夠靶向糾正基因突變，並調控基因表達，從而應用於治療、研究和診斷等領域。市場擴張的主要驅動力是精準醫療需求的不斷成長、基於CRISPR的RNA編輯工具的顯著進步以及對RNA編輯研究投入的持續增加。

市場概覽
預測期 2026-2030
2024年市場規模 2.6228億美元
2030年市場規模 3.9716億美元
2025-2030年複合年成長率 7.16%
成長最快的細分市場 信使RNA修飾
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球RNA編輯技術市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依RNA類型（信使RNA修飾、轉移RNA修飾、核醣體RNA修飾）
    • 按申請（癌症、遺傳性疾病、暫時性疾病）
    • 按技術（插入/刪除、脫氨基）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美RNA編輯技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲RNA編輯技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區RNA編輯技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲RNA編輯技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美RNA編輯技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球RNA編輯技術市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • ProQR Therapeutics NV
  • Sirna Therapeutics, Inc.
  • Shape Therapeutics, Inc.
  • Korro Bio, Inc.
  • Beam Therapeutics, Inc.
  • QIAGEN NV
  • UniQure NV (UniQure)
  • LAVA Therapeutics NV
  • argenx SE
  • Arrowhead Pharmaceuticals, Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 8075

The Global RNA Editing Technologies Market, valued at USD 262.28 Million in 2024, is projected to experience a CAGR of 7.16% to reach USD 397.16 Million by 2030. RNA editing technologies involve molecular processes that precisely modify specific nucleotide sequences within an RNA molecule after its transcription, distinct from permanent alterations to the genomic DNA. This enables targeted corrections of genetic mutations and modulation of gene expression for therapeutic, research, and diagnostic applications. The market's expansion is fundamentally driven by the increasing demand for precision medicine, significant advancements in CRISPR-based RNA editing tools, and growing investments in RNA editing research.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 262.28 Million
Market Size 2030USD 397.16 Million
CAGR 2025-20307.16%
Fastest Growing SegmentMessenger RNA Modification
Largest MarketNorth America

Key Market Drivers

The global RNA editing technologies market is profoundly influenced by two pivotal factors: significant advancements in RNA editing technologies and the increasing demand for precision and personalized medicine. Ongoing innovation in advanced gene editing platforms, particularly CRISPR-based systems and enhanced delivery mechanisms, continues to broaden the therapeutic applicability of RNA editing. For instance, according to the Innovative Genomics Institute, in March 2024, the UK's Medicines and Healthcare Products Regulatory Agency approved Casgevy for sickle cell disease and transfusion-dependent beta-thalassemia in November 2023, with subsequent FDA approval for sickle cell disease in December 2023, marking the first regulatory clearances for a CRISPR-based therapy.

Key Market Challenges

The technical complexity associated with efficient delivery and precise targeting systems for RNA editing components within specific cells and tissues represents a significant impediment to market expansion. This challenge directly affects the progression and success of therapeutic development by prolonging research and development timelines and escalating costs. The difficulty in developing safe and effective methods to introduce RNA editing tools precisely into target cells, without off-target effects or degradation, limits the scalability and broad application of these advanced therapies.

Key Market Trends

Increased cross-sectoral collaborations and partnerships are significantly driving growth in the Global RNA Editing Technologies Market by fostering shared expertise and resources. These alliances between biotechnology firms, pharmaceutical companies, and academic institutions accelerate the complex research and development cycle of RNA editing solutions. For example, in September 2024, Prime Medicine announced a strategic research collaboration and license agreement with Bristol Myers Squibb, which included a $55 million upfront payment and a $55 million equity investment, to develop ex vivo T-cell therapies using Prime Editing technology, demonstrating significant financial commitment to such joint ventures.

Key Market Players

  • ProQR Therapeutics NV
  • Sirna Therapeutics, Inc.
  • Shape Therapeutics, Inc.
  • Korro Bio, Inc.
  • Beam Therapeutics, Inc.
  • QIAGEN N.V.
  • UniQure NV (UniQure)
  • LAVA Therapeutics N.V.
  • argenx SE
  • Arrowhead Pharmaceuticals, Inc.

Report Scope:

In this report, the Global RNA Editing Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

RNA Editing Technologies Market, By Type of RNA:

  • Messenger RNA Modification
  • Transfer RNA Modification
  • Ribosomal RNA Modification

RNA Editing Technologies Market, By Application:

  • Cancer
  • Genetic Disorders
  • Temporary Maladies

RNA Editing Technologies Market, By Technique:

  • Insertion/Deletion
  • Deamination

RNA Editing Technologies Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global RNA Editing Technologies Market.

Available Customizations:

Global RNA Editing Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global RNA Editing Technologies Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type of RNA (Messenger RNA Modification, Transfer RNA Modification, Ribosomal RNA Modification)
    • 5.2.2. By Application (Cancer, Genetic Disorders, Temporary Maladies)
    • 5.2.3. By Technique (Insertion/Deletion, Deamination)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America RNA Editing Technologies Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of RNA
    • 6.2.2. By Application
    • 6.2.3. By Technique
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States RNA Editing Technologies Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of RNA
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Technique
    • 6.3.2. Canada RNA Editing Technologies Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of RNA
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Technique
    • 6.3.3. Mexico RNA Editing Technologies Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of RNA
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Technique

7. Europe RNA Editing Technologies Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of RNA
    • 7.2.2. By Application
    • 7.2.3. By Technique
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany RNA Editing Technologies Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of RNA
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Technique
    • 7.3.2. France RNA Editing Technologies Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of RNA
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Technique
    • 7.3.3. United Kingdom RNA Editing Technologies Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of RNA
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Technique
    • 7.3.4. Italy RNA Editing Technologies Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of RNA
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Technique
    • 7.3.5. Spain RNA Editing Technologies Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of RNA
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Technique

8. Asia Pacific RNA Editing Technologies Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of RNA
    • 8.2.2. By Application
    • 8.2.3. By Technique
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China RNA Editing Technologies Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of RNA
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Technique
    • 8.3.2. India RNA Editing Technologies Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of RNA
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Technique
    • 8.3.3. Japan RNA Editing Technologies Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of RNA
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Technique
    • 8.3.4. South Korea RNA Editing Technologies Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of RNA
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Technique
    • 8.3.5. Australia RNA Editing Technologies Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of RNA
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Technique

9. Middle East & Africa RNA Editing Technologies Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of RNA
    • 9.2.2. By Application
    • 9.2.3. By Technique
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia RNA Editing Technologies Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of RNA
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Technique
    • 9.3.2. UAE RNA Editing Technologies Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of RNA
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Technique
    • 9.3.3. South Africa RNA Editing Technologies Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of RNA
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Technique

10. South America RNA Editing Technologies Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of RNA
    • 10.2.2. By Application
    • 10.2.3. By Technique
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil RNA Editing Technologies Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of RNA
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Technique
    • 10.3.2. Colombia RNA Editing Technologies Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of RNA
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Technique
    • 10.3.3. Argentina RNA Editing Technologies Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of RNA
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Technique

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global RNA Editing Technologies Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. ProQR Therapeutics NV
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Sirna Therapeutics, Inc.
  • 15.3. Shape Therapeutics, Inc.
  • 15.4. Korro Bio, Inc.
  • 15.5. Beam Therapeutics, Inc.
  • 15.6. QIAGEN N.V.
  • 15.7. UniQure NV (UniQure)
  • 15.8. LAVA Therapeutics N.V.
  • 15.9. argenx SE
  • 15.10. Arrowhead Pharmaceuticals, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer